Related references
Note: Only part of the references are listed.The Global Success of Mycobacterium tuberculosis Modern Beijing Family Is Driven by a Few Recently Emerged Strains
Chendi Zhu et al.
MICROBIOLOGY SPECTRUM (2023)
The Mycobacterium tuberculosis PhoPR virulence system regulates expression of the universal second messenger c-di-AMP and impacts vaccine safety and efficacy
Irene Perez et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2022)
Recombinant BCG-LTAK63 Vaccine Candidate for Tuberculosis Induces an Inflammatory Profile in Human Macrophages
Carina C. dos Santos et al.
VACCINES (2022)
Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial
Mark F. Cotton et al.
LANCET INFECTIOUS DISEASES (2022)
Characterization of the Protective Immune Responses Conferred by Recombinant BCG Overexpressing Components of Mycobacterium tuberculosis Sec Protein Export System
Annuurun Nisa et al.
VACCINES (2022)
Recent Developments in Mycobacteria-Based Live Attenuated Vaccine Candidates for Tuberculosis
Mario Alberto Flores-Valdez et al.
BIOMEDICINES (2022)
MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies
Andrew D. White et al.
NPJ VACCINES (2021)
A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guerin
Joshua S. Woodworth et al.
NATURE COMMUNICATIONS (2021)
ESX-5-targeted export of ESAT-6 in BCG combines enhanced immunogenicity & efficacy against murine tuberculosis with low virulence and reduced persistence
Isis Heijmenberg et al.
VACCINE (2021)
A systematic approach to simultaneously evaluate safety, immunogenicity, and efficacy of novel tuberculosis vaccination strategies
Visai Muruganandah et al.
SCIENCE ADVANCES (2020)
Live attenuated TB vaccines representing the three modern Mycobacterium tuberculosis lineages reveal that the Euro-American genetic background confers optimal vaccine potential
Irene Perez et al.
EBIOMEDICINE (2020)
Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial
Michele Tameris et al.
LANCET RESPIRATORY MEDICINE (2019)
Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1+ KLRG1- CD4+ T cells
N. C. Bull et al.
MUCOSAL IMMUNOLOGY (2019)
Immune response elicited by two rBCG strains devoid of genes involved in c-di-GMP metabolism affect protection versus challenge with M. tuberculosis strains of different virulence
Cristian Alfredo Segura-Cerda et al.
VACCINE (2018)
MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic
Jesus Gonzalo-Asensio et al.
FRONTIERS IN IMMUNOLOGY (2017)
Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis
Martin Gengenbacher et al.
MBIO (2016)
Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis
Carolina Perdomo et al.
MBIO (2016)
Quest for Correlates of Protection against Tuberculosis
Kamlesh Bhatt et al.
CLINICAL AND VACCINE IMMUNOLOGY (2015)
Protection by novel vaccine candidates, Mycobacterium tuberculosis ΔmosR and ΔechA7, against challenge with a Mycobacterium tuberculosis Beijing strain
Sarah A. Marcus et al.
VACCINE (2015)
Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial
Francois Spertini et al.
LANCET RESPIRATORY MEDICINE (2015)
In search of a new paradigm for protective immunity to TB
Cludio Nunes-Alves et al.
NATURE REVIEWS MICROBIOLOGY (2014)
What is the efficiency of BCG?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2014)
Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis
A. Roy et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Evaluation of the Safety and Immunogenicity of a Candidate Tuberculosis Vaccine, MVA85A, Delivered by Aerosol to the Lungs of Macaques
A. D. White et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
Michele D. Tameris et al.
LANCET (2013)
Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials
Ainhoa Arbues et al.
VACCINE (2013)
Use of mouse models to study the variability in virulence associated with specific genotypic lineages of Mycobacterium tuberculosis
R. Hernandez-Pando et al.
INFECTION GENETICS AND EVOLUTION (2012)
The BCG world atlas: a new, open-access resource for clinicians and researchers
Alice Zwerling et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Host genetic background affects regulatory T-cell activity that influences the magnitude of cellular immune response against Mycobacterium tuberculosis
Marina Oliveira Paula et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Lysine Auxotrophy Combined with Deletion of the SecA2 Gene Results in a Safe and Highly Immunogenic Candidate Live Attenuated Vaccine for Tuberculosis
Joseph Hinchey et al.
PLOS ONE (2011)
Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells
Steven C. Derrick et al.
VACCINE (2011)
Phenotypic Definition of Effector and Memory T-Lymphocyte Subsets in Mice Chronically Infected with Mycobacterium tuberculosis
Marcela I. Henao-Tamayo et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Distinct functions of antigen-specific CD4 T cells during murine Mycobacterium tuberculosis infection
William W. Reiley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The second Geneva Consensus: Recommendations for novel live TB vaccines
K.B. Walker et al.
VACCINE (2010)
Transcriptional profiling of Mycobacterium tuberculosis during infection: lessons learned
Sarah K. Ward et al.
FRONTIERS IN MICROBIOLOGY (2010)
mosR, a Novel Transcriptional Regulator of Hypoxia and Virulence in Mycobacterium tuberculosis
Bassam Abomoelak et al.
JOURNAL OF BACTERIOLOGY (2009)
Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells
Thomas Lindenstrom et al.
JOURNAL OF IMMUNOLOGY (2009)
Vaccine-induced Immunity Circumvented by Typical Mycobacterium tuberculosis Beijing Strains
Kristin Kremer et al.
EMERGING INFECTIOUS DISEASES (2009)
Disseminated disease severity as a measure of virulence of Mycobacterium tuberculosis in the guinea pig model
Gopinath S. Palanisamy et al.
TUBERCULOSIS (2008)
Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial
Anthony Hawkridge et al.
BRITISH MEDICAL JOURNAL (2008)
Mycobacterial bacilli are metabolically active during chronic tuberculosis in murine lungs: Insights from genome-wide transcriptional profiling
Adel M. Talaat et al.
JOURNAL OF BACTERIOLOGY (2007)
High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection
Sandra Hervas-Stubbs et al.
INFECTION AND IMMUNITY (2006)
Transcriptional responses in mouse lungs induced by vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis
HJ Mollenkopf et al.
MICROBES AND INFECTION (2006)
The temporal expression profile of Mycobacterium tuberculosis infection in mice
AM Talaat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis
AS Pym et al.
NATURE MEDICINE (2003)
Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti
AS Pym et al.
MOLECULAR MICROBIOLOGY (2002)
Specialized transduction:: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M-bovis BCG and M-smegmatis
S Bardarov et al.
MICROBIOLOGY-SGM (2002)
Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β
C Manca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates
DA Smith et al.
INFECTION AND IMMUNITY (2001)
Share Paper
